Assets
(4 total)
4Total Assets
0Approved
1Phase 3 / Filed
3Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | Angiotensin II type 1 receptor / L-type calcium channel / Na-Cl cotransporterSmall molecule | Hypertension | |
| Phase 1 | Undisclosed / early pipeline | Atherosclerotic Cardiovascular Disease | |
| Phase 1 | Undisclosed / early pipeline | Atherosclerotic Cardiovascular Disease | |
| Phase 1 | Undisclosed / early pipeline | Atherosclerotic Cardiovascular Disease |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.